Abstract
Atypical teratoid rhabdoid tumor (AT/RT) is a highly malignant embryonal tumor of the central nervous system (CNS), which occurs sporadically or in the setting of a rhabdoid predisposition syndrome. A peak incidence of AT/RTs is found in children aged less than 3 years at diagnosis. In this age group ATRT occurs as frequently as medulloblastoma, the most common malignant pediatric CNS tumor.The characteristic morphological feature of AT/RT is the presence of rhabdoid tumor cells and varying amounts of small -undifferentiated PNET-like, mesenchymal, and/or epithelial differentiated tumor cells. The morphological and imaging similarities with supratentorial PNETs and medulloblastomas may result in misclassification. The vast majority of AT/RTs are characterized by alterations of the SMARCB1 (hSNF5/INI1) gene that encodes a ubiquitously expressed protein. Alterations of SMARCB1 lead to loss of nuclear protein expression, which can be detected by an immunohistochemical staining.Currently, no definitive guidelines for optimal treatment have been established. Most recent treatment strategies recommend maximal safe surgery followed by multimodal therapy, including intensive chemotherapy often augmented with intrathecal therapy with or without high-dose chemotherapy (HDC), and focal or craniospinal irradiation. With this approach prolonged survival can be achieved in a proportion of patients.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.